November 9 coronavirus news | CNN

November 9 coronavirus news

Salt Lake County Health Department public health nurses look on during coronavirus testing outside the department in Salt Lake City on Tuesday, November 3.
US averaging 100,000 new Covid-19 infections per day
01:58 - Source: CNN

What you need to know

  • More than 50 million cases of Covid-19 have been recorded worldwide, as countries hit frightening new records globally.
  • The US has surpassed 10 million cases of coronavirus.
  • One of President-elect Joe Biden’s first priorities is tackling the pandemic, his transition team announced. He is expected to name a12-person coronavirus task force in the coming days.
  • Pfizer says early analysis shows its Covid-19 vaccine is 90% effective.
  • The EU hailed the success of its cross-border Covid-19 contact tracing system.
69 Posts

World Health Organization begins global coronavirus meeting -- without representatives from Covid-19 success story

Members and observer states of the World Health Organization (WHO) met virtually for the 73rd World Health Assembly on Monday, with WHO director-general Tedros Adhanom Ghebreyesus saying in his opening remarks that the world needed to work together to end the coronavirus pandemic.

But one of the governments with the best track record on containing Covid-19 wasn’t in attendance at the meeting. They weren’t even allowed to observe.

Taiwan, a self-governed island of 24 million people, has only recorded 578 infections and seven deaths from the novel coronavirus, despite its close proximity to the center of the initial outbreak in mainland China.

Only countries which are members of the United Nations can become members of the WHO, and Taiwan has not been represented at the UN since 1971.

Beijing still claims Taiwan as part of its territory and has repeatedly put pressure on international institutions for decades, including the WHO, to not give the island a country-level status. This is despite Taiwan being separately governed from the mainland since 1949.

Taiwan has been fiercely campaigning to be allowed into the WHO or at the very least to be given observer status. On Twitter, the Taiwan Ministry of Foreign Affairs has been pushing the hashtag #TaiwanCanHelp.

But despite its best attempts, Taiwan was excluded when the WHO leaders met on Monday.

“The Foreign Ministry expresses strong regret and dissatisfaction at China’s obstruction of Taiwan participating in the WHO and the WHO’s continuing to neglect the health and human rights of Taiwan’s 23.5 million people,” Taipei said in a statement, according to Reuters.

Brazil’s Health Surveillance Agency suspends Phase 3 trials of China's CoronaVac vaccine

Vials of Sinovac Biotech Ltd.'s CoronaVac SARS-CoV-2 vaccine are displayed at a media event in Beijing, China, on September 24.

Brazil’s National Health Surveillance Agency (Anvisa) has suspended phase 3 clinical trials of a Chinese-developed Covid-19 vaccine following an “adverse” incident involving a volunteer recipient, according to sources cited by CNN’s affiliate, CNN Brasil.

CoronaVac, developed by Chinese pharmaceutical company Sinovac Biotech, began phase 3 trials of CoronaVac in collaboration with the Brazilian Butantan Institute in Sao Paulo in late July.

According to CNN Brasil, the studies were suspended due to the “occurrence of serious adverse event in one of the volunteers in Brazil.” No further details were provided owing to privacy regulations.

The pause in testing marks a potential setback for one of China’s leading vaccine candidates and comes as US drugmaker Pfizer said Monday that early data from its own coronavirus vaccine showed more than 90% effectiveness.

In a note obtained by CNN Brasil, Anvisa mentions a case on October 29 for which the agency “determined the interruption of the clinical study,” adding that it “decided to interrupt the study to evaluate the data observed so far and judge on the risk/benefit of continuing the study.”

“With the study interrupted, no new volunteers can be vaccinated,” reads the Anvisa note published by CNN Brasil late Monday.

The CoronaVac trial vaccine uses inactivated virus cells to stimulate an immune response in patients. Testing began in late July, with 9,000 volunteers in five Brazilian states plus the capital. 

The Butantan Institute said it will hold a press conference Tuesday morning local time, according to CNN Brasil.

Pfizer seeks to reassure that its Covid-19 vaccine is safe, that “no corners were cut”

“No corners were cut” in the development of Pfizer’s 2-dose coronavirus vaccine, the company’s vice president of research and development, Dr. John Burkhardt, said at a news conference in Connecticut Monday.

Burkhardt said what’s been unusual in the development of its Covid-19 vaccine is that the company started the manufacturing process at the same time it was developing the vaccine, something that is not usually done.

“Normally you wouldn’t spend $1 billion to manufacture a product that may not work. You wait to see whether it works and whether it’s safe and then you do the manufacturing. So, we did that at risk,” he said. 

It was a decision made very early in the process to save time, Burkhardt said. He also credited “great volunteerism” in getting 43,000 people enrolled in the clinical trials as a time saver in the development process.

Pfizer announced Monday that early efficacy data on its Covid-19 vaccine appears to be more than 90% effective, much better than expected.

Pfizer says 42% of volunteers in Covid-19 vaccine trials are from diverse backgrounds

Almost half of the volunteers in Pfizer’s Phase 3 clinical trials for a coronavirus vaccine are from diverse backgrounds, the company’s vice president of research and development, Dr. John Burkhardt, said at a news conference in Connecticut Monday.

“Our approach has been to really enroll lots of patients, gain lots of diversity in that population, go into the places where we can enroll diversity and then to learn from that data as it plays out in the study,” Burkhardt said.

Pfizer is studying 43,000 patients in its vaccine trials, he said, and 42% are from ethnic and racial backgrounds that are considered diverse.

It’s unclear whether the vaccine may not benefit some populations or if there might be side effects associated with it.

“We don’t have the sub-level of detail to answer those, but we believe we’ve got the kind of clinical trial design and some simple data set that will be very informative,” he said.

Pfizer announced Monday that early data on its Covid-19 vaccine shows it appears to be more than 90% effective at preventing infection.

New Mexico sees highest single-day Covid-19 case load

Samples are collected at a new Covid-19 testing site on the campus of New Mexico State University in Las Cruces on Thursday, Nov. 5.

The US state of New Mexico reported its highest number of new Covid-19 cases Monday, with 1,418 infections.

New Mexico previously reported its highest daily case load on Friday, with 1,287 new cases and recorded the exact same figure the following day.

The Department of Health said the state’s Intensive Care Units are at 66% capacity. That includes both Covid and non-Covid ICU patients.

Pfizer expects "logistical challenge" in distributing vaccine at freezing temperatures, if it's authorized

The distribution of Pfizer’s two-dose coronavirus vaccine will be a “logistical challenge” because the shot needs to be stored at freezing temperatures, according to Dr. John Burkhardt, Pfizer’s vice president of Global Drug Safety Research and Development.

“We’re working very hard on that,” he said. “There’s a whole suite of very experienced and talented people at Pfizer who are solely working on this, an army of people, and so it’s going to be important to work with the authorities with state governments and others to provide that supply chain.” 

State health officials have expressed concerns about the requirements for Pfizer’s vaccine, which must be stored at extremely cold temperatures of -94 Fahrenheit (-70 Celsius) – far below the capacity of standard freezers.

It’s unclear how long Pfizer’s vaccine will offer protection from Covid-19, Burkhardt said. Pfizer will follow the volunteers in the clinical trials for two years “with an emphasis on safety” but will also collect other types of data, he added.

“We just need some time for this to play out,” Burkhardt said when asked whether the vaccine might help prevent more severe cases of Covid-19 or asymptomatic cases.

He emphasized Pfizer’s years of experience in vaccine development and said “no corners were cut” with this one.

“We followed this tried and true methodology that has worked so well for us in the past and continues to deliver really superior and safe products,” he added. 

Burkhardt said what was unusual this time was that the company started the manufacturing process at the same time it was developing the vaccine – something that is not usually done.

Burkhardt also credited “great volunteerism” in getting 43,000 people enrolled in the clinical trials as a time-saver in the development process.

“We also moved over 150 sites for clinical studies, and we were able to really emphasize locations where virus was spreading more quickly,” he said.

FDA gives emergency authorization to Eli Lilly's monoclonal antibody treatment for coronavirus

The US Food and Drug Administration said Monday it had issued an emergency use authorization for Eli Lilly and Co’s investigational monoclonal antibody therapy bamlanivimab to treat mild to moderate coronavirus infections in adults and children.

“The FDA’s emergency authorization of bamlanivimab provides health care professionals on the frontline of this pandemic with another potential tool in treating COVID-19 patients,” Dr. Patrizia Cavazzoni, acting director of the FDA’s Center for Drug Evaluation and Research, said in the statement. “We will continue to evaluate new data on the safety and efficacy of bamlanivimab as they become available.”

Road to authorization: The FDA authorization was based on a study published in the New England Journal of Medicine in October. It found that the treatment seemed to lower the risk of hospitalization and ease some symptoms in a small number of patients with mild to moderate case Covid-19.

The Phase 2 trial involved 452 patients, some of whom received the treatment and some of whom received a placebo.

Only 1.6% of patients who received the treatment had to be hospitalized or seek care at the emergency room. For patients who got the placebo, the rate of hospitalization was 6.3%. 

Eli Lilly announced it had struck a $375 million deal with the government for 300,000 vials of the antibody treatment, pending emergency use authorization, to be delivered in the two months after.

The company said it planned to have 100,000 doses ready to ship within days and would manufacture a million doses by the end of 2020. The treatment would be provided to patients at no cost.

The FDA said that based on its review of the evidence available, it was “reasonable to believe that bamlanivimab may be effective in treating non-hospitalized patients with mild or moderate COVID-19” and that “the known and potential benefits outweigh the known and potential risks for the drug.”

Fauci says he has "no intention of leaving" role as NIAID director

Dr. Anthony Fauci.

Dr. Anthony Fauci said Monday that he plans to remain in his role as director of the National Institute of Allergy and Infectious Diseases through the remainder of the Trump administration and into President-elect Joe Biden’s administration.

“It’s an important job, and my goal is to serve the American public, no matter what the administration is,” he added.

Fauci warned that the United States was in a “serious situation” with cases exceeding 100,000 a day, but said the country “can turn it around.”

He said “help is on the way with a vaccine,” following the announcement by Pfizer on Monday that early data shows its vaccine is 90% effective.

The Data and Safety Monitoring Board, an independent group that monitors vaccine trials, “has … told us that we now have a vaccine that is more than 90% effective,” said Fauci.

“Obviously, we need to go over the details of the data, but this is a highly reputable company that has extensive experience in the development of countermeasures, including vaccines,” Fauci said.

He said there were still questions about how long the vaccine would protect people for, and how effective it is in the elderly versus younger people, but that it was “good news” both in the immediate term and for other vaccines from companies such as Moderna, which work along similar lines.

He emphasized, though, that while Americans should feel good about the news, no one should let their guard down yet.

“We know there’s light at the end of the tunnel, but that doesn’t mean that we’re going to give up the important public health measures that we continually still have to do every single day,” said Fauci.

Every county in Ohio "feeling the brunt of rising Covid-19 hospitalizations"

A Medical Worker in full PPE prepares to conduct Covid-19 tests on patients at The Ohio State East Hospital on July 31 in Columbus, Ohio.

Ohio is seeing “an unprecedented spike in hospitalization, and it is impacting all areas of the state,” Bruce Vanderhoff, incoming chief medical officer at the Ohio Department of Health said in a news conference on Monday.  

Vanderhoff said waves of the virus in the spring and summer were much smaller and everyone was able to pull together and reduce spread and avoiding overwhelming hospitals.

While Ohio has more PPE and capacity than they did in the spring, cases are surging and the demands on staffing are increasing. “Every county in the state is feeling the brunt of rising Covid-19 hospitalizations,” he said. 

In the spring, Governor Mike DeWine worked with the Ohio Hospital Association to create a comprehensive statewide public health system, bringing together hospitals and healthcare providers to support each other during the pandemic.

Ohio is not the only state in which hospitals are under increased pressure.

Connecticut Governor Ned Lamont said on Monday that hospitalizations there had doubled in the past few weeks. Fatalities have also been increasing monthly for the past three months.

But Lamont said that hospital capacity was not an issue at this time and that only 50% of the ICU is currently in use. 

SEC football programs forced to change plans due to Covid-19

An 'SEC' logo is seen on an end zone pylon before the Missouri Tigers take on the Auburn Tigers during the SEC Championship Game at Georgia Dome on December 7, 2013 in Atlanta, Georgia.

Saturday’s college football game between Auburn and Mississippi State has been postponed due to Covid-19 cases within Mississippi State’s program.

The Southeastern Conference (SEC) announced the Bulldogs have had positive tests and are subsequently quarantining. 

The game has been tentatively rescheduled for December 12. 

Louisiana State’s head football coach Ed Orgeron admitted on Monday that several of the team’s players, including starters, have Covid and are quarantining.

When asked about the status of Saturday’s game against Alabama, Orgeron said it was “very fluid right now.”

No. 5 Texas A&M were forced to halt their football activities on Monday after receiving multiple positive coronavirus tests. 

US reported record 74,000 new Covid-19 cases among children last week

There were nearly 74,000 new cases of Covid-19 among children in the US in the week ending November 5 – the highest weekly increase since the pandemic began, according to the American Academy of Pediatrics. 

Children account for more than 11% of all coronavirus cases in the US. There has been a 17% increase in Covid-19 cases among children over the past two weeks.

The AAP said 73,883 new cases among children 17 and under were reported from October 29 to November 5, with about 927,518 children infected in the US in total. More than 10 million people have been infected in the US.

Severe illness and deaths from Covid-19 are still rare among children.

As of November 5, children represented between 1% and 3.4% of total hospitalizations, depending on the state. Between 0.6% and 6.4% of all child cases resulted in hospitalization and in states that reported the information, up to 0.13% of children with Covid-19 died. Sixteen states reported no child deaths.  

The count is not complete, because not all states report data in the same way. These numbers come from 49 states, New York City, the District of Columbia, Puerto Rico and Guam. A smaller subset of states report information about hospitalizations and deaths by age. 

The AAP said there was an “urgent need” to collect more data on the longer-term impact of Covid-19 on children, including the ways in which the virus may hurt children physically and emotionally over time.

Vaccine maker Novavax gets FDA fast-track for experimental coronavirus shot

Vaccine maker Novavax said Monday it had won fast-track designation for its experimental coronavirus vaccine from the US Food and Drug Administration – something that could help speed regulatory approval or emergency use authorization.

That would make it the fifth coronavirus vaccine to enter late-stage clinical trials in the US. Vaccines being made by Moderna and Pfizer have also received FDA fast-track designation.

The Maryland-based company has been awarded $1.6 billion from the federal government’s Operation Warp Speed to help it run clinical trials of the vaccine.

Like several other experimental coronavirus vaccines, Novavax’s would require two doses. It hopes deliver 100 million doses by the end of this year.

Novavax’s vaccine is made by growing synthetic versions of the coronavirus spike protein in armyworm moth cells. The vaccine combines these particles with the company’s adjuvant – a plant-based compound that helps boost the immune response to the vaccine.

California hospitalizations rise by more than 25% as governor warns people are "letting their guard down"

Coronavirus rates are rising quickly in California with cases, positivity rate, hospitalizations, and the number of people in intensive care all climbing.

Hospitalizations are up 28.6% over the past two weeks and the number of patients in ICU has increased 27.3% over the past three weeks, Governor Gavin Newsom announced Monday.

The positivity rate has gone up significantly in that time frame, from a low of 2.5% on October 19 to 3.7% today.

Newsom said the reason for the increase was obvious. 

Testing for coronavirus is also climbing in California, with 194,000 tests conducted on Sunday. 

“We anticipated seeing more cases with increased testing, but the positivity rate is a better indicator of what’s actually happening,” Newsom said.

Newsom said he expects an announcement on Tuesday that some counties will move backwards in the state’s tier system. For some areas, that could include closing some non-essential business and reinstituting stricter health orders.

Michigan State basketball coach Tom Izzo tests positive for Covid-19

In this Jan. 12, 2020, file photo, Michigan State coach Tom Izzo gestures during the second half of the team's NCAA college basketball game against Purdue in West Lafayette, Indiana

Michigan State’s men’s basketball coach Tom Izzo tested positive for coronavirus Monday morning, he said in a statement.

Izzo said he had “some minor symptoms,” but remained in good health.

Izzo said technology would allow him to stay connected with his staff and players, and he would be following advice from medical staff, and taking all the steps necessary to return as soon as possible. 

He said he was “proof that no one is immune,” but urged people to listen to experts and take steps to reduce their chances of contracting the virus.

Pfizer vaccine "not a magic bullet," emergency physician cautions

A health worker wearing a protective mask works in a lab during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, on Wednesday, September 9.

Despite promising early results from Pfizer’s trials, the coronavirus vaccine is “not a magic bullet,” Dr. Leana Wen, emergency physician and CNN medical analyst, said Monday.

The drugmaker announced Monday that its vaccine appears to be more than 90% effective, based on early data. Wen said that efficacy figure refers to the vaccine’s ability to prevent any Covid-19 infection, as opposed to severe infection from the virus.

Wen said she hopes Pfizer will make its data publicly available. The company is expected to do so when it applies to the US Food and Drug Administration for emergency use authorization.

Wen added that “there is a long road between actually getting the vaccine approved and getting it distributed to hundreds of millions of Americans,” emphasizing the importance of basic public health measures in the meantime.

As hospital capacity shrinks, Utah Governor hopes increased testing will help with Covid-19 surge

In this Thursday, April 30, file photo, health care workers look on during a flyover at the University of Utah Hospital in Salt Lake City.

Utah Governor Gary Herbert said Monday that the state’s hospitals were almost at capacity, explaining this was the reason a state of emergency and statewide mask mandate were declared yesterday.

Utah’s Covid-19 dashboard reports that 78.2% of the state’s ICU beds are currently occupied. The state hit record highs in its 7-day case average and test positivity percentage today, which reached 2,437.4 and 21.25% Monday.

He laid the blame for the surge in Covid-19 cases largely with young people and “unstructured events.”

“It is coming from these casual gatherings where we get together with family and friends and, probably, our guard goes down – we’re a little more complacent,” the governor said.

He said the highest infection rates were among 15- to 24-year-olds, and said he would “accelerate the testing program today” to include college students, who he said should be tested once a week.

The Governor said this was “less about government mandates and us telling you what to do – it’s more about taking personal responsibility.”

 Herbert also bemoaned the injection of politics into the pandemic response nationwide.

“I think it is, in fact, unfortunate that we’ve had this pandemic during a political year,” he said. “The politics has gotten in the way of really doing the right thing and the right way as soon as we can and uniting the public.”

Italy declares five more "orange zones" as official says epidemic is worsening

Soldiers patrol Milan's main train station in Italy on Saturday, November 7.

Italy has declared five more coronavirus “orange zones” in which tighter restrictions will come into effect, starting Wednesday and lasting at least two weeks.

The regions of Abruzzo, Umbria, Toscana, Liguria and Basilicata will join Puglia and Sicily, which were declared orange zones last Wednesday.

The restrictions mean that:

  • “Non-essential” shops will close
  • Bars and restaurants are limited to serving takeout
  • Residents are restricted from leaving their towns

Lombardy, Valle d’Aosta, Piedmont and Calabria were declared “red zones” last week – residents there face the tightest restrictions, including stay-at-home orders except for work, study, health and “essential needs.”

Small-scale street protests, by local residents angry at Italy’s central government, took place in several red zone areas on the eve of the lockdowns.

Stricter measures have also been imposed starting from Monday on the autonomous province of Bolzano – Alto Adige in northern Italy, because of an increase in cases there. 

Rezza said the average transmission (R) rate is 1.7 in Italy, which has more than 500 positive Covid-19 cases per 100,000 citizens. 

“We also notice an increase in hospitalizations and in people that required intensive care,” Rezza said, adding: “this situation justified the further restrictions.”

On Monday, Italy registered an increase of 100 patients needing intensive care, bringing the total ICU admissions to 2,849, Health Ministry daily figures show. 

There were 356 deaths, bringing the total to 41,750, and 25,271 new positive cases reported in the last 24 hours, taking the country’s total to 960,373.

Trump adviser tapped to oversee campaign's legal challenges tests positive for coronavirus, sources say

An adviser for President Donald Trump’s campaign, David Bossie, has tested positive for coronavirus only days after he was tapped to oversee legal challenges contesting the outcome of the election, two sources confirmed to CNN. 

Bossie did not immediately respond to a request for comment. He has been in the campaign headquarters in Virginia several times in the last week and has traveled extensively.

Bloomberg News first reported the diagnosis. 

Earlier Monday, CNN confirmed that Housing and Urban Development Secretary Ben Carson had tested positive for coronavirus.

Read the full story here:

david bossie 1105

Related article Trump adviser overseeing campaign legal challenges gets coronavirus, sources say

French health agency director says second wave of coronavirus has yet to peak

Director General of Health Jerome Salomon speaks during a press conference on the Covid-19 pandemic in Paris, France, on November 5.

The second wave of coronavirus has yet to peak in France, the country’s national health agency director Jerome Salomon said on Monday in Paris.

Salomon said the second wave was affecting all metropolitan areas, but he added that cities where a curfew and other restrictions were put in place early are now beginning to observe a slower progression of the epidemic.

On Monday, France reported 20,155 new coronavirus cases, with 551 deaths occurring in the last 24 hours in French hospitals. France has reported a total of 1,807,479 cases and 40,987 deaths since the start of the pandemic, according to Salomon and the latest data from the National Health Agency.

Salomon noted that France ranks fourth highest in the world for total cases.

New Jersey Governor announces highest number of hospitalizations since June

New Jersey Governor Phil Murphy announced 1,537 new hospitalizations across the state on Sunday – the first time the state has exceeded 1,500 hospitalizations since June 9.

Murphy also announced new restrictions for bars, restaurants and indoor youth sports across the state.

The governor said 2,075 new Covid 19 cases and 11 additional deaths had been recorded on Monday; the state’s positivity rate is 7.52%. Since the last news conference on Thursday, 9,524 new cases have been reported. Hospitalizations are up, but ventilator use is down overall, according to Murphy. 

New rules for bars and restaurants:

  • From November 12, all restaurants, bars, clubs and lounges must close their indoor dining areas by 10 p.m., but they can continue to offer outdoor dining and takeout.
  • Since bars have seen such a high rate of transmission, all bar-side seating will be prohibited for now.
  • To help restaurants with limited seating, the state will allow tables to be closer than 6 feet if there are physical barriers between them. 
  • Outdoor bubble seating will be allowed, as long as they are thoroughly cleaned between use, and only used by one group at a time.

All interstate games and tournaments for indoor youth sports will be prohibited starting Thursday, Murphy said. 

Murphy told reporters that the state was “taking surgical steps to help mitigate the increasing spread” of Covid seen across the state.

He urged New Jersey residents to “shake off” Covid fatigue, encouraging the state to crush the curve, as it did in the spring.